Others

Aarti Drugs Ltd. - Outcome Of Board Meeting Held Today I.E. Wednesday, May 15, 2019 Pursuant To Regulation 33 And Regulation 30 Read With Para A Of Part A Of Schedule III Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

| Updated on May 15, 2019 Published on May 15, 2019

Pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we inform you that the Board of Directors at its Meeting held today i.e. Wednesday, May 15, 2019 had inter-alia considered and approved the following:-

a)Statement of Audited Financial Results (Standalone & Consolidated) for the Quarter & year ended March 31, 2019 (attached);

b)The Audit Report(s) by M/s. Kirtane & Pandit LLP, Chartered Accountants, the Statutory Auditors of the Company on the Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2019 along with the declaration in respect of Audit Report(s) with unmodified opinion for the Financial Year ended on March 31, 2019 (attached);

c)Recommended the Final Dividend @ Rs. 1/-(Rupee One) i.e. (10%) per share of Rs. 10/- each for the Financial year ended 2018-2019.

Pdf Link: Aarti Drugs Ltd. - Outcome Of Board Meeting Held Today I.E. Wednesday, May 15, 2019 Pursuant To Regulation 33 And Regulation 30 Read With Para A Of Part A Of Schedule III Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 15, 2019
This article is closed for comments.
Please Email the Editor